AMERICAN BENEFITS COUNCIL for AMERICAN BENEFITS COUNCIL
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Retirement RET
ERISA Preemption Tax treatment of retirement plans Proposed regulation regarding investment selection in retirement plans (designated investment alternatives) Tax treatment of retiree health accounts (S. 2003) Market-based cash balance plans Pooled Employer Plans (PEPs) and non-PEP Multiple Employer Plans Defined benefit and defined contribution retirement plans Caregiver retirement savings catch-up credit (S. 4291/ HR 8273) Trump (child savings) accounts - nondiscrimination rules and dependent care assistance programs non-discrimination rules Trump IRAs - SAVERS MATCH Roth Catch-up - treatment of tips Automatic re-enrollment of unenrolled plan participants (S. 1831) Reduction of required age for participation in retirement plans from 21 to 18 (S. 1707 / HR 4718) Pension Benefit Guaranty Corporation - penalty reporting Charity Parity Act (S. 4511 / HR 8783) Collective Investment Trusts and Insurance Company Separate Accounts
| Lobbyist | Covered position, as disclosed |
|---|---|
| LYNN DIEHL DUDLEY | — |
| DIANN HOWLAND | Pension Policy Director for the Senate Health Education Labor and Pensions Committee, Pension Policy Advisor of the Senate Finance Committee |
Health Issues HCR
ERISA Preemption Tax treatment of employer-sponsored health benefit plans Site-neutral payment policies, anti-competitive practices, hospital consolidation, and reforms No Surprises Act reforms and HR 4710 Patients Deserve Price Tags Act (HR 5582/ S 2355) Excepted fertility benefits DOL NPRM Pharmacy Benefit Fee Disclosure (sec. 408(b)(2)) Electronic disclosure for health and welfare benefit plans Employer Innovations in Health Care Sec. 340B pharmacy drug pricing program End-Stage Renal Disease, Restore Protections for Dialysis Patients Act (HR 2199) Lower Costs More Transparency Act (HR 9393) Chronic disease coverage, on-site clinics, direct primary care Mental Health Parity and Addiction Equity Act (MHPAEA) Health care price transparency, prescription drug price transparency, PBM price transparency, hospital price transparency ERISA fiduciary duties for health care plans (S. 3345 / S. 526) Prescription Drug Data Collection reporting Medicare Operations Rule
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANN HOWLAND | Pension Policy Director for the Senate Health Education Labor and Pensions Committee, Pension Policy Advisor of the Senate Finance Committee |
| KATHRYN JOHNSON | Attorney advisor, Office of Benefits Tax Counsel at the U.S. Department of Treasury; attorney, Office of Chief Counsel at the Internal Revenue Service |
| MATTHEW MUMA | Legislation Counsel with the Joint Committee on Taxation; Attorney-Adviser with the Department of the Treasury |
| ILYSE SCHUMAN | Senate HELP Committee, Chief Labor Counsel, Minority Staff Director |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.